Skip to content
Screener

Inspire Medical Systems INSP Q2 2026 earnings

Reported August 3, 2026 · After market close

Revenue$200.6MBeat by $5.9M
EPS$0.14Beat by $0.38
Revenue estimate$194.7M
EPS estimate-$0.24
“Our second quarter results reflect the increased discipline and focus we are bringing to the business as we continue to support customers through the evolving coding and reimbursement environment and invest in the long-term adoption of Inspire therapy. We are also announcing a strategic growth plan designed to generate approximately $30 million of annualized growth investment capacity, which we intend to redeploy into targeted growth initiatives. We believe these actions will strengthen our operating foundation, sharpen our focus on the highest-return opportunities, and position Inspire for sustainable growth and long-term value creation.”
Tim Herbert

Next report

Nov 2, 2026 (Today)
Revenue estimate$204.3M
EPS estimate$0.09

Financials

Q2 2026

Income statement

See full
Revenue$200.6M-7.6%
Gross profit$171.5M-6.0%
Operating income-$514.0K+84.5%
Net income$314.0K+109%
EPS (diluted)$0.01+108%

Balance sheet

See full
Cash & equivalents$127.8M+19.5%
Total debt$29.1M-12.0%
Total equity$825.6M+21.8%
Total assets$926.0M+15.4%

Cash flow

See full
Operating cash flow$23.2M—
CapEx$9.2M+1.8%
Free cash flow$14.1M+323%

Valuation & ratios

Valuation

as of 10/30/26
See full
Market cap$2.06B-4.8%
Enterprise value$1.96B-5.8%
P/E15.2×-33.3×
P/S2.3×-0.2×

Profitability

See full
Gross margin86.1%+1.7pp
Operating margin6%+1.2pp
Net margin15%+8.9pp
FCF margin13%+3.2pp

Returns & leverage

See full
Return on equity18%+9.9pp
Debt / equity0×0.0×
Current ratio8.6×+2.4×

Segments

By segment

See full
Operating Segment$200.6M-7.6%

FAQ

When did Inspire Medical Systems report Q2 2026 earnings?
Inspire Medical Systems (INSP) reported Q2 2026 earnings on August 3, 2026 after market close.
What were Inspire Medical Systems's Q2 2026 revenue and EPS?
Inspire Medical Systems reported revenue of $200.6M and eps of $0.14 for Q2 2026.
Did Inspire Medical Systems beat estimates in Q2 2026?
Revenue beat the consensus estimate of $194.7M by $5.9M. EPS beat the consensus estimate of $-0.24 by $0.38.
How did Inspire Medical Systems's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 7.6% from $217.1M a year earlier and eps declined 68.9% from $0.45.
Where can I find Inspire Medical Systems's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001609550-26-000045) and the 10-Q periodic report (0001609550-26-000047) directly on SEC EDGAR. The filing index links above go to sec.gov.